# Eximias Pharmaceutical Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eximias-pharmaceutical

- Industry: Pharmaceuticals
- Headquarters: Berwyn, US
- Total disclosed funding: $87M
- Latest round: Series D (Mar 31, 2004)
- Investors on record: 15

## About

Eximias Pharmaceuticals is a pharmaceuticals company developing late stage cancer therapeutics.

## Funding rounds

- Series D, Mar 31, 2004, $64M — Cross Atlantic Capital Partners, New Enterprise Associates, OrbiMed Advisors, Quaker Partners Management, Easton Capital Investment Group, Emerging Technology Partners, Cross Atlantic Partners, Pacific Rim Ventures, Birchmere
- Series C, Oct 4, 2000, $24M — Ontario Teachers' Pension Plan, CDPQ, BioAsia Investments, Veron International, New York Life Investment Management, EJ Financial Enterprises

## Investors

- Ontario Teachers' Pension Plan — Series C
- CDPQ — Series C
- BioAsia Investments (https://capitalatlas.ai/funds/bioasia-investments) — Series C
- Veron International — Series C
- New York Life Investment Management — Series C
- EJ Financial Enterprises (https://capitalatlas.ai/funds/ej-financial-enterprises) — Series C
- Cross Atlantic Capital Partners (https://capitalatlas.ai/funds/cross-atlantic-capital-partners) — Series D
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series D
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series D
- Quaker Partners Management (https://capitalatlas.ai/funds/quaker-partners-management) — Series D
- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series D
- Emerging Technology Partners (https://capitalatlas.ai/funds/emerging-technology-partners) — Series D
- Cross Atlantic Partners (https://capitalatlas.ai/funds/cross-atlantic-partners) — Series D
- Pacific Rim Ventures (https://capitalatlas.ai/funds/pacific-rim-ventures) — Series D
- Birchmere (https://capitalatlas.ai/funds/birchmere) — Series D